IDYA
Price
$15.56
Change
-$0.79 (-4.83%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
1.36B
39 days until earnings call
RCKT
Price
$5.55
Change
-$0.75 (-11.90%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
591.79M
38 days until earnings call
Ad is loading...

IDYA vs RCKT

Header iconIDYA vs RCKT Comparison
Open Charts IDYA vs RCKTBanner chart's image
IDEAYA Biosciences
Price$15.56
Change-$0.79 (-4.83%)
Volume$20.67K
Capitalization1.36B
Rocket Pharmaceuticals
Price$5.55
Change-$0.75 (-11.90%)
Volume$62.39K
Capitalization591.79M
IDYA vs RCKT Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. RCKT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and RCKT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (IDYA: $15.57 vs. RCKT: $5.55)
Brand notoriety: IDYA and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 154% vs. RCKT: 244%
Market capitalization -- IDYA: $1.36B vs. RCKT: $591.79M
IDYA [@Biotechnology] is valued at $1.36B. RCKT’s [@Biotechnology] market capitalization is $591.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, RCKT is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • RCKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both IDYA and RCKT are a good buy in the short-term.

Price Growth

IDYA (@Biotechnology) experienced а -10.67% price change this week, while RCKT (@Biotechnology) price change was -29.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

IDYA is expected to report earnings on May 13, 2025.

RCKT is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.36B) has a higher market cap than RCKT($592M). IDYA YTD gains are higher at: -36.381 vs. RCKT (-55.847). RCKT has higher annual earnings (EBITDA): -247.48M vs. IDYA (-323.14M). IDYA has more cash in the bank: 676M vs. RCKT (372M). IDYA has less debt than RCKT: IDYA (19.2M) vs RCKT (25.5M). IDYA has higher revenues than RCKT: IDYA (7M) vs RCKT (0).
IDYARCKTIDYA / RCKT
Capitalization1.36B592M230%
EBITDA-323.14M-247.48M131%
Gain YTD-36.381-55.84765%
P/E RatioN/AN/A-
Revenue7M0-
Total Cash676M372M182%
Total Debt19.2M25.5M75%
FUNDAMENTALS RATINGS
IDYA vs RCKT: Fundamental Ratings
IDYA
RCKT
OUTLOOK RATING
1..100
5658
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
28
Undervalued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
9496
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (28) in the Biotechnology industry is in the same range as IDYA (60) in the null industry. This means that RCKT’s stock grew similarly to IDYA’s over the last 12 months.

IDYA's Profit vs Risk Rating (71) in the null industry is in the same range as RCKT (100) in the Biotechnology industry. This means that IDYA’s stock grew similarly to RCKT’s over the last 12 months.

IDYA's SMR Rating (95) in the null industry is in the same range as RCKT (97) in the Biotechnology industry. This means that IDYA’s stock grew similarly to RCKT’s over the last 12 months.

IDYA's Price Growth Rating (94) in the null industry is in the same range as RCKT (96) in the Biotechnology industry. This means that IDYA’s stock grew similarly to RCKT’s over the last 12 months.

IDYA's P/E Growth Rating (100) in the null industry is in the same range as RCKT (100) in the Biotechnology industry. This means that IDYA’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYARCKT
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 22 days ago
77%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VENAX65.29N/A
N/A
Vanguard Energy Index Admiral
DLRHX23.02N/A
N/A
Macquarie Healthcare R
OSCCX19.09N/A
N/A
Invesco Main Street Small Cap C
GEORX5.72N/A
N/A
Pear Tree Essex Environmental Opps R6
BKRDX7.93-0.20
-2.46%
iShares Developed Real Estate Idx K

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+10.70%
GRI - IDYA
54%
Loosely correlated
-17.33%
KRYS - IDYA
51%
Loosely correlated
+3.68%
RCKT - IDYA
50%
Loosely correlated
+8.43%
IMNM - IDYA
49%
Loosely correlated
+7.19%
XENE - IDYA
49%
Loosely correlated
+2.68%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with DNLI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-11.90%
DNLI - RCKT
57%
Loosely correlated
-6.91%
NTLA - RCKT
57%
Loosely correlated
-5.75%
RGNX - RCKT
54%
Loosely correlated
-5.39%
AXON - RCKT
52%
Loosely correlated
-3.35%
CRSP - RCKT
51%
Loosely correlated
-4.47%
More